Table 1.
Imaging Features on US | Total(n = 120) | P* | |
---|---|---|---|
HAE (n = 60) |
ICC (n = 60) |
||
Conventional US | |||
Location | 0.002 | ||
Right lobe | 50 (83.3) | 33 (55.0) | |
Left lobe | 10 (16.7) | 27 (45.0) | |
Lesion size | 0.851 | ||
≤ 5.0 cm | 22 (36.7) | 24 (40.0) | |
> 5.0 cm | 38 (63.3) | 36 (60.0) | |
Echogenicity | 0.000 | ||
Hyper or Iso | 10 (16.7) | 7 (11.6) | |
Mixed | 43 (71.7) | 19 (31.7) | |
Hypo | 7 (11.6) | 34 (56.7) | |
Margin | 1.000 | ||
Clear | 28 (46.7) | 28 (46.7) | |
Unclear | 32 (53.3) | 32 (53.3) | |
Bile duct dilatation | 2 (3.3) | 21 (35.0) | 0.000 |
Pseudocystic appearance | 14 (23.3) | 1 (1.7) | 0.000 |
Calcification | 29 (48.3) | 0 (0) | 0.000 |
CEUS | |||
Arterial phase | 0.008 | ||
Hyper- | 39 (65.0) | 50 (83.3) | |
Iso- | 10 (16.7) | 9 (15.0) | |
Hypo- or Non- | 11 (18.3) | 1 (1.7) | |
Enhancement pattern | 0.000 | ||
Regular rim | 53 (88.3) | 6 (10.0) | |
Irregular rim | 6 (10.0) | 29 (48.4) | |
Heterogeneous | 1 (1.7) | 14 (23.3) | |
Homogeneous | 0 (0) | 11 (18.3) | |
Portal phase | 0.000 | ||
Hyper- | 1 (1.7) | 0 (0) | |
Iso- | 19 (31.6) | 1 (1.7) | |
Hypo- or Non- | 40 (66.7) | 59 (98.3) | |
Late phase | 0.000 | ||
Hyper- | 1 (1.7) | 0 (0) | |
Iso- | 16 (26.6) | 1 (1.7) | |
Hypo- or Non- | 43 (71.7) | 59 (98.3) | |
Enhancement duration# | 201.7 ± 146.4 | 33.5 ± 59.5 | 0.000 |
Marked wash-out | 15 (25.0) | 44 (73.3) | 0.000 |
Note.---Unless otherwise indicated, data are number of nodules, with percentages in parentheses
*Statistical analysis using χ2 or Fisher’s exact test demonstrate differences between HAE and ICC
# Data are means± standard deviations
HAE Hepatic alveolar echinococcosis; ICC Intrahepatic cholangiocarcinoma; US Ultrasound; CEUS Contrast enhanced ultrasound